phenylalanine has been researched along with Fukuhara Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Filosto, M; Galli, R; Mancuso, M; Murri, L; Pizzanelli, C; Siciliano, G | 1 |
Alfonzo, JD; Fredrick, K; Ibba, M; Ling, J; Qin, D; Roy, H; Rubio, MA | 1 |
2 other study(ies) available for phenylalanine and Fukuhara Disease
Article | Year |
---|---|
Antimyoclonic effect of levetiracetam in MERRF syndrome.
Topics: Activities of Daily Living; Anticonvulsants; Atrophy; Brain; Drug Therapy, Combination; Female; Genetic Predisposition to Disease; Humans; Levetiracetam; MERRF Syndrome; Middle Aged; Mitochondria; Muscle, Skeletal; Mutation; Myoclonus; Phenylalanine; Piracetam; Quality of Life; RNA, Transfer; Treatment Outcome; Ubiquinone; Valproic Acid | 2006 |
Pathogenic mechanism of a human mitochondrial tRNAPhe mutation associated with myoclonic epilepsy with ragged red fibers syndrome.
Topics: Anticodon; Base Sequence; Epilepsies, Myoclonic; Humans; Kinetics; MERRF Syndrome; Mitochondria; Molecular Conformation; Molecular Sequence Data; Mutation; Nucleic Acid Conformation; Peptide Elongation Factor Tu; Phenylalanine; RNA; RNA, Mitochondrial; RNA, Transfer, Phe | 2007 |